:::

詳目顯示

回上一頁
題名:Patient Characteristics and Treatment Discontinuation in a Taiwanese Cohort of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study
書刊名:Taiwanese Journal of Psychiatry
作者:林喬祥蕭正誠黃玉書呂少鈞盧孟良臧汝芬魯思翁West, Teena Maree沈武典
作者(外文):Lin, Chaucer Chiao-hsiangHsiao, Cheng-chengHuang, Yu-shuRee, Shao-chunLu, Mong-liangTzang, Ruu-fenLuu, Sy-uengShen, Winston W.
出版日期:2010
卷期:24:2
頁次:頁110-121+162
主題關鍵詞:精神分裂症觀察性研究治療中斷時間SchizophreniaObservational studyTime to discontinuationOlanzapine
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:59
期刊論文
1.Csernansky, J. G.、Schuchart, E. K.(2002)。Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics。CNS Drugs,16,473-484。  new window
2.Tan, Chay H.、Shinfuku, Naotaka、Si, Tianmei、Ungvari, Gabor S.、Chung, Eun K.、Sim, Kang、Su, Alex、Heckers, Stephan、Chan, Yiong H.、曾憲洋、張明永、楊淑媛、Fujii, Senta(2004)。Antipsychotic Polypharmacy in Patients with Schizophrenia: A Multicentre Comparative Study in East Asia。British Journal of Clinical Pharmacology,58(2),178-183。  new window
3.Miyamoto S,、Duncan GE,、Marx CE,、Lieberman JA.(2005)。Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs。Mol Psychiatry,10,79-104。  new window
4.蘇東平、陳曾基、黃信彰、周麗芳、范佩真、陳育群(20020800)。Utilization of Psychotropic Drugs in Taiwan: An Overview of Outpatient Sector in 2000。中華醫學雜誌,65(8),378-391+CA62。  延伸查詢new window
5.Tollefson GD, Sanger TM(1997)。Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine。Am J Psychiatry,154,466-74。  new window
6.Shen, Winston W.(2004)。Antidepressants are under-used in Taiwan。臺灣精神醫學,18(2),77-78。  new window
7.EuroQol Group(1990)。A new facility for the measurement of health-related quality of life。Health Policy,16(3),199-208。  new window
8.Lieberman, J. A.、Stroup, T. S.、McEvoy, J. P.、Swartz, M. S.、Rosenheck, R. A.、Perkins, D. O.、Hsiao, J. K.(2005)。Effectiveness of antipsychotic drugs in patients with chronic schizophrenia。New England Journal of Medicine,353(12),1209-1223。  new window
9.American Psychiatric Association(1997)。Practice guideline for the treatment of patients with schizphrenia。Am J Psychiatry,154 (Suppl 2),1-63。  new window
10.Sullivan G, Wells KB, Morgenstern H, Leake B(1995)。Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi。Am J Psychiatry,152,1749-56。  new window
11.Valenstein M, Copeland LA, Blow FC, et al.(2002)。Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission。Med Care,40,630-9。  new window
12.Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW(2006)。Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care。J Clin Psychiatry,67,453-60。  new window
13.Saleem P, Olie JP, Loo H(2002)。Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride。Int Clin Psychoparmacol,17,1-8。  new window
14.Corrigan PW, Reinke RR, Landsberger SA, Charate A, Toombs GA(2003)。The effects of atypical antipsychotic medications on psychosocial outcomes。Schizophr Res,63,97-101。  new window
15.Lehman AF, Lieberman JA, Dixon LB, et al.(2004)。Practice guidelines for the treatment of patients with schizophrenia, second edition。Am J Psychiatry,161(Suppl 2),1-56。  new window
16.Lee P, Kim CE, Kim CY, et al.(2008)。Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO)。Int J Psychiatry Clinical Practice,12(3),215-227。  new window
17.Lee C, Wu KH, Habil H, Dyachkova Y, Lee P(2006)。Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia。Aust NZ J Psychiatry,40,437-45。  new window
18.Haro JM, Kamath SA, Ochoa S, et al.(2003)。The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia。Acta Psychiatr Scand,Suppl,16-23。  new window
19.Huang SS, Liao YC, Hsieh YY, et al(2006)。Combination antipsychotic therapy in psychiatric outpatients clinics in Taiwan。Compr Psychiatry,47,421-5。  new window
20.Shen WW(1981)。A drug information note for patients receiving antiparkinsonian agents。Hosp Community Psychiatry,32,575。  new window
21.Keck PE Jr, Strakowski SM, McElroy SL(2000)。The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia。J Clin Psychiatry,61 (Suppl 3),4-9。  new window
22.Kelly DL, Conley RR, Carpenter WT(2005)。First-episode schizophrenia: a focus on pharmacological treatment and safety considerations。Drugs,65,1113-38。  new window
23.Sebastian CS, Glazer W, Buckley PF(2004)。Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia。Curr Med Chem,11,329-42。  new window
24.Tran PV, Hamilton SH, Kuntz AJ, et al.(1997)。Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders。J Clin Psychopharmacol,17,407-18。  new window
25.Kahn RS, Fleischhacker WW, Boter H, et al.(2008)。Effectiveness of antipsychotic drugs in first episode schizophrenia and schizophreniform disorder: an open randomised clinical trial。Lancet,371,1085-1097。  new window
26.Basson BR, Kinon BJ, Tor CC, Szymanski KA, Gilmore JA, Tollefson GD(2001)。Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone。J Clin Psychiatry,62,231-8。  new window
27.Allison DB, Casey DE(2001)。Antipsychotic-induced weight gain: a review of the literature。J Clin Psychiatry,62 (Suppl 7),22-31。  new window
28.Weiden PJ, Mackell JA, McDonnell DD(2004)。Obesity as a risk factor for antipsychotic noncompliance。Schizophr Res,66,51-7。  new window
29.Bobes J, Rejas J, Garcia-Garcia M, et al(2003)。Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study。Schizophr Res,62,77-88。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE